Epileptic seizures and rhinocerebral mucormycosis during blinatumomab treatment in a patient with biphenotypic acute leukemia

Ann Hematol. 2017 Jan;96(1):151-153. doi: 10.1007/s00277-016-2837-1. Epub 2016 Oct 3.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Antibodies, Bispecific / adverse effects*
  • Antineoplastic Agents / adverse effects*
  • Brain Diseases / chemically induced*
  • Brain Diseases / complications
  • Brain Diseases / diagnostic imaging
  • Epilepsy / chemically induced*
  • Epilepsy / complications
  • Epilepsy / diagnostic imaging
  • Fatal Outcome
  • Female
  • Humans
  • Leukemia, Biphenotypic, Acute / complications
  • Leukemia, Biphenotypic, Acute / diagnostic imaging
  • Leukemia, Biphenotypic, Acute / drug therapy*
  • Mucormycosis / chemically induced*
  • Mucormycosis / complications
  • Mucormycosis / diagnostic imaging
  • Young Adult

Substances

  • Antibodies, Bispecific
  • Antineoplastic Agents
  • blinatumomab